News & AnalysisTeon Therapeutics gathers $30m Series ATeon Therapeutics, a biopharmaceutical company, has closed $30 million in Series A financing.ByIris Dorbian23 February 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs